Patents by Inventor STEFANIE KERN

STEFANIE KERN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11372000
    Abstract: The present disclosure relates to an antibody that specifically binds a mutated NT-proBNP having i) a mutation substituting arginine at position 46 with histidine or ii) a mutation substituting glutamic acid at position 43 with aspartic acid. Moreover, the present disclosure relates to a mutated NT-proBNP or fragment thereof. Further, envisaged by the present disclosure are kits containing the antibody of the present disclosure, or the mutated NT-proBNP of the present disclosure. The present disclosure also concerns a method for diagnosing heart failure.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 28, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Klaus Hallermayer, Monika Soukupova, Christina Porzig, Ulrike Kurtkaya, Leopold Von Proff, Sonja Fiesel, Marion Herrmann, Stefanie Kern
  • Publication number: 20190369117
    Abstract: The present disclosure relates to an antibody that specifically binds a mutated NT-proBNP having i) a mutation substituting arginine at position 46 with histidine or ii) a mutation substituting glutamic acid at position 43 with aspartic acid. Moreover, the present disclosure relates to a mutated NT-proBNP or fragment thereof. Further, envisaged by the present disclosure are kits containing the antibody of the present disclosure, or the mutated NT-proBNP of the present disclosure. The present disclosure also concerns a method for diagnosing heart failure.
    Type: Application
    Filed: August 13, 2019
    Publication date: December 5, 2019
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Klaus Hallermayer, Monika Soukupova, Christina Porzig, Ulrike Kurtkaya, Leopold Von Proff, Sonja Fiesel, Marion Herrmann, Stefanie Kern
  • Patent number: 10378008
    Abstract: The present invention relates to a novel method for automated processing of pooled samples, particularly blood samples. Furthermore, the present invention pertains to an apparatus for carrying out the method and the corresponding uses. The method, and accordingly, the apparatus, can be used in particular to perform nucleic acid amplification techniques (NAT) for testing blood donations and blood products.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: August 13, 2019
    Assignee: GFE BLUT MBH
    Inventors: Willi Kurt Roth, Stefanie Kern
  • Publication number: 20170211058
    Abstract: The present invention relates to a novel method for automated processing of pooled samples, particularly blood samples. Furthermore, the present invention pertains to an apparatus for carrying out the method and the corresponding uses. The method, and accordingly, the apparatus, can be used in particular to perform nucleic acid amplification techniques (NAT) for testing blood donations and blood products.
    Type: Application
    Filed: August 5, 2015
    Publication date: July 27, 2017
    Inventors: WILLI KURT ROTH, STEFANIE KERN